Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model
- PMID: 16117788
- DOI: 10.1111/j.0022-202X.2005.23831.x
Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model
Abstract
RDP58 is the first lead compound in a series of immunomodulating decapeptides discovered through activity-based screening and computer-aided, rational design. RDP58 disrupts cellular responses signaled through the Toll-like and tumor necrosis factor (TNF) receptor families and occludes important signal transduction pathways involved in inflammation, inhibiting the production of tumor necrosis factor alpha (TNFalpha), interferon-gamma, interleukin (IL)-2, IL-6, and IL-12. These pro-inflammatory cytokines are thought to be involved in the pathogenesis of several inflammatory and autoimmune diseases, including atopic dermatitis and psoriasis. The goal of this study was to determine the ability of RDP58 to inhibit skin inflammation following exposure to the well-characterized protein kinase C activator and tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Topical application of RDP58 to the epidermis following TPA treatment resulted in the amelioration of the phorbol ester-induced irritant contact dermatitis. Substantial reductions were observed in skin thickness and tissue weight, neutrophil-mediated myeloperoxidase activity, inflammatory cytokine production, and various histopathological indicators. We also found RDP58 to be effective in reducing the compounding inflammatory damage brought on by chronic TPA exposure, and that it is capable of targeting inflammatory mediators specifically in the keratinocyte. These results demonstrate that topically applied RDP58 is an effective anti-inflammatory treatment in the phorbol ester-induced dermatitis model, and suggest that it may have therapeutic potential in a variety of immune-related cutaneous diseases.
Similar articles
-
Caffeic acid reduces cutaneous tumor necrosis factor alpha (TNF-α), IL-6 and IL-1β levels and ameliorates skin edema in acute and chronic model of cutaneous inflammation in mice.Biol Pharm Bull. 2014;37(3):347-54. doi: 10.1248/bpb.b13-00459. Biol Pharm Bull. 2014. PMID: 24583856
-
Anti-inflammatory effects of Asparagus cochinchinensis extract in acute and chronic cutaneous inflammation.J Ethnopharmacol. 2009 Jan 12;121(1):28-34. doi: 10.1016/j.jep.2008.07.006. Epub 2008 Jul 18. J Ethnopharmacol. 2009. PMID: 18691647
-
Anti-inflammatory activity of Chrysanthemum indicum extract in acute and chronic cutaneous inflammation.J Ethnopharmacol. 2009 May 4;123(1):149-54. doi: 10.1016/j.jep.2009.02.009. Epub 2009 Feb 14. J Ethnopharmacol. 2009. PMID: 19429354
-
IL-20: a new target for the treatment of inflammatory skin disease.Expert Opin Ther Targets. 2003 Apr;7(2):165-74. doi: 10.1517/14728222.7.2.165. Expert Opin Ther Targets. 2003. PMID: 12667095 Review.
-
Oxidative stress in allergic and irritant dermatitis: from basic research to clinical management.Recent Pat Inflamm Allergy Drug Discov. 2012 Sep;6(3):202-9. doi: 10.2174/187221312802652839. Recent Pat Inflamm Allergy Drug Discov. 2012. PMID: 22827837 Review.
Cited by
-
Machine learning for predicting lifespan-extending chemical compounds.Aging (Albany NY). 2017 Jul 18;9(7):1721-1737. doi: 10.18632/aging.101264. Aging (Albany NY). 2017. PMID: 28783712 Free PMC article.
-
Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation.Pharmaceuticals (Basel). 2020 Dec 21;13(12):484. doi: 10.3390/ph13120484. Pharmaceuticals (Basel). 2020. PMID: 33371334 Free PMC article.
-
In vivo Anti-inflammatory Activity of Lipidated Peptidomimetics Pam-(Lys-βNspe)6-NH2 and Lau-(Lys-βNspe)6-NH2 Against PMA-Induced Acute Inflammation.Front Immunol. 2020 Aug 28;11:2102. doi: 10.3389/fimmu.2020.02102. eCollection 2020. Front Immunol. 2020. PMID: 32983167 Free PMC article.
-
Acyclic monoterpenoid-rich essential oil of Cymbopogon distans mitigates skin inflammation: a chemico-pharmacological study.Inflammopharmacology. 2024 Feb;32(1):509-521. doi: 10.1007/s10787-023-01302-0. Epub 2023 Aug 5. Inflammopharmacology. 2024. PMID: 37541972
-
RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.J Autoimmun. 2008 Jun;30(4):257-65. doi: 10.1016/j.jaut.2007.10.005. Epub 2007 Dec 26. J Autoimmun. 2008. PMID: 18162370 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials